{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:01:44Z","timestamp":1775221304260,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jdcr.2024.05.033","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T23:09:35Z","timestamp":1718060975000},"page":"88-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Seronegative cutaneous rheumatoid nodules with positive response to tofacitinib"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-7393","authenticated-orcid":false,"given":"Matthew","family":"Helm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calista","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galen","family":"Foulke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2024.05.033_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/rheumatology\/keaa623","article-title":"Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study","volume":"60","author":"Paalanen","year":"2021","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"3","key":"10.1016\/j.jdcr.2024.05.033_bib2","first-page":"554","article-title":"Seronegative rheumatoid arthritis: one year in review 2023","volume":"41","author":"De Stefano","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.jdcr.2024.05.033_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40744-020-00258-9","article-title":"Update on the safety profile of tofacitinib in rheumatoid arthritis from clinical trials to real-world studies: a narrative review","volume":"8","author":"\u00c1lvaro-Gracia","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"3","key":"10.1016\/j.jdcr.2024.05.033_bib4","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jaad.2019.06.1297","article-title":"Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disorders","volume":"82","author":"Rosenbach","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2024.05.033_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.15013","article-title":"A large pulmonary nodule in a rheumatoid arthritis patient treated with tofacitinib","volume":"27","author":"Her","year":"2024","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.jdcr.2024.05.033_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/24725625.2020.1777677","article-title":"A case of rheumatoid arthritis with multiple lung rheumatoid nodules successfully treated with tofacitinib","volume":"5","author":"Kondo","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.jdcr.2024.05.033_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738481","article-title":"Tofacitinib suppresses several JAK-STAT pathways in rheumatoid arthritis in\u00a0vivo and baseline signaling profile associates with treatment response","volume":"12","author":"Palmroth","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jdcr.2024.05.033_bib9","first-page":"187","article-title":"The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature","volume":"93","author":"Wang","year":"2020","journal-title":"Yale J Biol Med"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624002157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624002157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T16:07:33Z","timestamp":1723306053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624002157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":8,"alternative-id":["S2352512624002157"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.05.033","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seronegative cutaneous rheumatoid nodules with positive response to tofacitinib","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}